University of Central Florida

STARS
Honors Undergraduate Theses

UCF Theses and Dissertations

2019

Development of Luminescent Tools for Use in the Study of
Mycobacterium tuberculosis
Krista A. Moore
University of Central Florida

Part of the Respiratory Tract Diseases Commons

Find similar works at: https://stars.library.ucf.edu/honorstheses
University of Central Florida Libraries http://library.ucf.edu
This Open Access is brought to you for free and open access by the UCF Theses and Dissertations at STARS. It has
been accepted for inclusion in Honors Undergraduate Theses by an authorized administrator of STARS. For more
information, please contact STARS@ucf.edu.

Recommended Citation
Moore, Krista A., "Development of Luminescent Tools for Use in the Study of Mycobacterium tuberculosis"
(2019). Honors Undergraduate Theses. 478.
https://stars.library.ucf.edu/honorstheses/478

DEVELOPMENT OF LUMINESCENT TOOLS FOR USE IN THE STUDY OF
MYCOBACTERIUM TUBERCULOSIS

by

KRISTA A. MOORE

A thesis submitted in partial fulfillment of the requirements
for the Honors in the Major Program in Biomedical Sciences
in the College of Medicine
and in the Burnett Honors College
at the University of Central Florida
Orlando, Florida

Spring Term, 2019

Thesis Chair: Kyle Rohde, Ph.D.

ABSTRACT
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, is a growing
problem worldwide due to the emergence of multi-drug resistant and extensively-drug resistant
strains of the bacteria. A key to combatting the spread of these strains lies in the understanding of
gene expression occurring in Mtb. This study focuses on the development and optimization of a
luciferase-based bioluminescent transcriptional reporter that can be used to monitor gene
expression in Mtb. The luminescent signal emitted from the reporter can be measured and
correlated with the level of transcription of certain genes. This study focuses specifically on a
gene called whiB7 which encodes a transcription factor known to contribute to the drug
resistance of Mtb. The drug-inducible whiB7 promoter was cloned into various locations in the
luciferase plasmid in order to determine the ideal configuration of the reporter for maximum
luminescence. The optimized luciferase reporter was then compared with a fluorescent
transcriptional reporter, mCherry, also under control of the whiB7 promoter. Fluorescent
reporters present some disadvantages including delayed kinetics and inability to accurately
reflect gene downregulation due to long half-life of reporter proteins. It was hypothesized that
the luciferase reporter would solve these problems by offering a more sensitive and dynamic tool
to monitor gene expression. Quantitative real-time PCR was used to measure whiB7 mRNA
present in cultures containing either the luciferase or mCherry reporters. The luminescent and
fluorescent signal given from these reporters was then compared to actual mRNA expression. It
was observed that the signal from the luciferase reporter more closely matched mRNA
expression at each timepoint, indicating that the luciferase reporter is a better gauge of actual
gene expression levels than the mCherry reporter.
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1. INTRODUCTION
Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis (TB), the
deadliest infectious disease globally. In fact, in 2016 there were 1.7 million reported deaths from
TB [1]. This disease primarily affects the lungs and respiration, but may spread to other organ
systems. Thanks to developments in the treatment of TB with antibiotics, the annual number of
TB deaths is dropping. The standard recommended treatment for TB involves at least a sixmonth regimen of four antibiotics: isoniazid, rifampicin, pyrazinamide, and ethambutol [2].
However, the emergence of drug resistant strains of TB has become a growing concern among
scientists and physicians. Approximately twenty percent of TB isolates globally are estimated to
be resistant to at least one major antibiotic [3]. Multi-drug resistant (MDR) TB is defined by the
World Health Organization as resistance to at least isoniazid and rifampicin while extensively
drug-resistant (XDR) TB has the same characteristics as MDR but also has resistance to
fluoroquinolones and second-line injectable drugs. XDR TB has even evolved to totally drug
resistant (TDR) strains in some parts of the world that have endemic TB, including China, India,
and South Africa [3].
1.1 Drug resistance
Drug resistance can arise because of mutations occurring in the TB genome that cause
drug targets or certain enzymes to be altered or due to the activation of efflux pumps used to
remove drug when it enters the bacterium [3]. Additionally, poor compliance of patients with the
extensive drug regimen required to treat TB can be a problem that ultimately leads to the
development of drug-resistant strains of TB. However, studies have shown that even when a
patient follows his or her drug regimen precisely and the treatment appears curative, some active
1

Mtb may still be present in the patient [4]. Most patients with MDR or XDR TB present first
with resistance to one antibiotic, then over time clonal selection allows these resistant bacteria to
outcompete others. These more impervious bacteria will develop other single-nucleotide
polymorphisms or mutations, allowing them to gain resistance to other antibiotics as well. This
method of developing resistance is termed secondary resistance [3]. Primary resistance, on the
other hand, occurs when already resistant strains are transmitted from an infected to non-infected
host [3].
The threat to the public that MDR and XDR TB pose cannot be understated. In South
Africa, for example, the MDR and XDR TB typically make up only 5% of TB cases, but these
cases are estimated to utilize over one-third of the resources allocated to the management of TB
[3]. With the rise of international travel and migration, TB is no longer only a threat to
individual countries, but to nations around the world. Therefore, because of the global threat to
public health that MDR and XDR TB pose, the need for the identification of new drugs and drug
targets in TB is becoming increasingly important. In order to identify new drug targets, hostpathogen interactions involved in TB infection must be understood.
1.2 Gene Expression
Mtb has evolved extensive mechanisms to prevent eradication by the host immune
system. One method that Mtb uses for survival is the ability to colonize and replicate within host
macrophages, immune cells that typically break down pathogens to prevent them from further
invading host tissue [5]. The adaptations used by Mtb to survive in such a hostile environment
are still under investigation. However, it is known that differential gene expression is harnessed
by Mtb over the course of infection to respond and adapt to the many challenges presented by the
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host immune system [6]. These gene expression differences may also be central to the
mechanisms used by Mtb to resist the harsh effects presented by many antibiotics.
Gene expression can be monitored in vitro and in vivo using multiple methods including
quantitative real-time PCR (qRT-PCR), fluorescent reporters, and bioluminescent transcriptional
reporters. This study will focus on developing and optimizing a bioluminescent transcriptional
reporter for use in the study of Mtb and comparing the efficacy of this reporter with other
commonly used reporter technologies.
1.3 Transcriptional Reporters
A transcriptional reporter is a fusion of genetic regulatory elements to reporter proteins
that produce detectable outputs, allowing gene expression to be monitored [7]. There are many
different types of transcriptional reporters currently in use, including those based on fluorescent
proteins, colorimetric enzymes, and drug resistance genes. These reporters are often used to
study how transcription is affected by different factors such as the presence of drugs or a change
in environmental stimuli.
Transcriptional reporter genes have multiple uses both in the study of Mtb and in the
study of other bacteria. For example, these transcriptional reporters have been used to identify
the mechanism of action of drugs against TB [8], for measuring dynamic protein-protein
interactions in bacterial systems that may be important for pathogenesis [9], and in in vivo in live
mice to view the localization of TB throughout infection [10].
1.4 Fluorescent Transcriptional Reporters
Fluorescent transcriptional reporters are commonly used in the study of Mtb, including
the mCherry reporter. mCherry is a red fluorescent protein derived from the Discosoma sp.
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mushroom coral [11]. mCherry is widely used because of its monomeric structure, high
brightness, and fast maturation [11]. However, mCherry does have some disadvantages when
compared to other transcriptional reporter technologies. While the fluorescent signal from
mCherry is bright, detectable signal does not accurately reflect transcript levels. It may take
hours for this signal to build up to a detectable level as the fluorescent protein accumulates. The
mCherry protein also takes time to fold and mature to an actively fluorescent form. This may
hinder understanding of the kinetics of gene expression in response to certain stimuli. In
addition, the mCherry reporter can only show upregulation of transcription signaling because the
fluorescent protein has a long half-life and does not degrade efficiently [7]. Because of this,
once the fluorescence is stimulated, its levels will not decrease again to show decreasing
transcription. For this reason, alternatives to fluorescent reporters that may offer more dynamic
readings of gene expression in real-time are being explored.
1.5 Bioluminescent Transcriptional Reporters
Bioluminescent transcriptional reporters may offer a solution to the problems presented
by fluorescent transcriptional reporters. Bioluminescence is the production of light by chemical
reactions catalyzed by an enzyme known as luciferase [10]. Luciferases are a family of enzymes
that catalyze reactions in which a substrate, generally called a luciferin, is oxidized with
associated production of light [10]. Light is emitted when the product, in an electronically
excited state, emits a photon upon returning to ground state [12]. Multiple organisms naturally
express luciferase, including fireflies, marine organisms, and certain bacteria. The luciferase
system used in this study originates from the bacterium Photorhabdus luminescens. This
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luciferase system was chosen because it does not require exogenously added substrate, making
its use simpler as well as less toxic to living cells [12].
The Photorhabdus luminescens luciferase is encoded by an operon called luxCDABE.
The luxAB genes are responsible for encoding the luciferase enzyme, an -heterodimeric
luciferase [13]. The luxCDE gene cluster encodes the enzymatic complex that synthesizes the
substrate, a long-chain aldehyde [13]. The bioluminescence reaction occurs as follows [12]:
𝐹𝑀𝑁𝐻2 + 𝑅𝐶𝐻𝑂 + 𝑂2 → 𝐹𝑀𝑁 + 𝑅𝐶𝑂𝑂𝐻 + 𝐻2 𝑂 + 𝑙𝑖𝑔ℎ𝑡
Luciferase binds to reduced flavin mononucleotide (𝐹𝑀𝑁𝐻2 ), molecular oxygen, and a longchain fatty aldehyde. A redox reaction occurs in which 𝐹𝑀𝑁𝐻2 is oxidized to flavin
mononucleotide (FMN), and the fatty aldehyde is oxidized to a fatty acid. This process emits a
blue photon with a spectral emission maximum of 490 nm [12]. The intensity of this blue light
can be measured using a spectrometer. Through genetic engineering of the luxCDABE plasmid,
the luciferase operon can be used as a tool to measure transcription.
The luciferase plasmid used in this experiment, pMV306Lux+Hsp60+G13, contains the
luciferase operon split into two segments, LuxAB and LuxCDE, because this configuration yields
the best reporter performance [13]. This plasmid includes the LuxAB segment under the control
of a constitutive promoter hsp60 (Phsp60) which controls the formation of enzyme. The LuxCDE
segment is under the control of the constitutive G13 promoter (PG13), controlling the formation of
the substrate [13]. Previous studies performed in E. coli have also shown that in order to get the
highest signal possible, the LuxAB genes should be under the control of an inducible promoter
while the LuxCDE genes should be under the control of a constitutive promoter [13]. This result
shows that the availability of aldehyde, the substrate formed by LuxCDE, is the rate limiting
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factor in this operon, so it should be constitutively available. This study will involve replacing
either of the two constitutive promoters in pMV306Lux+Hsp60+G13 with a drug-inducible
promoter. In this way, the promoter configuration that gives the highest signal and most accurate
dynamic readout will be optimized for use in future studies in Mycobacteria.
1.6 The whiB7 Gene
In order to evaluate different luciferase reporter configurations for optimization, a wellcharacterized, drug-inducible promoter, PwhiB7, was used. WhiB7 is a transcriptional regulator of
certain genes in Mtb that contribute to the intrinsic multi-drug resistance seen in the bacteria
[14]. PwhiB7 responds to the presence of certain antibiotics that inhibit protein synthesis by
activating its own expression. WhiB7 also acts as a transcriptional activator of many drug
resistance genes [15]. Specifically, WhiB7 binds to a protein known as SigA, a primary sigma
factor subunit of RNA polymerase [15]. In this way, WhiB7 is able to activate systems of
intrinsic drug resistance including antibiotic export systems such as efflux pumps, antibiotic
inactivation systems that modify certain drugs or drug targets, and redox balance changes within
the bacteria [16]. Therefore, monitoring the gene expression of the WhiB7 transcriptional
activator in response to different environmental stimuli could lead to important insights into how
to block this protein from stimulating intrinsic antibiotic resistance.
A homolog for the whiB7 gene in Mtb exists in Mycobacterium smegmatis (Msm), a
relative of Mtb that can be safely used in Biosafety Level 2 laboratories and has been shown to
be induced by similar antibiotics as Mtb PwhiB7 [14]. Therefore, Msm PwhiB7 can be induced by the
addition of the antibiotics azithromycin (AZT) and clarithromycin (CLR). These drugs are
classified as macrolides which bind to the 50S subunit of the bacterial ribosome and inhibit
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protein synthesis [17]. When these antibiotics are added to cultures of Msm containing the
luciferase operon under control of PwhiB7, PwhiB7 will be induced, resulting in a higher
luminescent output compared to the unmodified luciferase operon. In order to monitor whiB7
gene expression, PwhiB7 will be cloned into the pMV306Lux+Hsp60+G13 plasmid in place of
PG13 or Phsp60. These modified transcriptional reporters will be used to optimize the luciferase
operon for monitoring gene expression in Mycobacteria as well as to test the efficacy of the
luciferase system in comparison to other reporters.
1.7 Measuring Real-Time Gene Expression
In order to determine which reporter—luciferase or mCherry— is most accurate,
expression of whiB7 RNA in Msm must be measured in real-time. Quantitative real-time PCR
(qRT-PCR) will be used to determine the level of whiB7 RNA being made by Msm containing
the luciferase or mCherry reporters at specific time points after induction by antibiotics. This
real-time expression level will be compared to the luminescent and fluorescent signals being
given off by each transcriptional reporter at each time point. This will allow conclusions to be
drawn about which reporter gives readings with kinetics that are most similar to real-time gene
expression. This study seeks to validate that the luciferase transcriptional reporter offers
measurements of transcription that are closer to real-time than those seen using the fluorescent
mCherry reporter.
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2. OBJECTIVES
Objective 1: Development of a Luciferase-Based Transcriptional Reporter
A luciferase-based transcriptional reporter will be developed by modifying the
lucCDABE operon in the plasmid pMV306Lux+Hsp60+G13. The constitutive promoters
controlling the LuxAB genes and the LuxCDE genes will be replaced with the inducible, PwhiB7,
causing the reporter to respond to the presence of antibiotics. The luminescence of bacteria
containing one of these new reporter plasmids will be measured after exposure to certain
antibiotics.
Objective 2: Comparative Analysis of the Luciferase Transcriptional Reporter
The signaling of the luciferase reporter will be compared to that of another commonly
used fluorescent transcriptional reporter, mCherry, also under the control of the drug-inducible
PwhiB7. Quantitative real-time PCR will be performed on the bacteria containing either the
luciferase or mCherry reporters to compare luminescent and fluorescent readouts with actual
mRNA levels.
Objective 3: Enhancing Luminescent Signaling
To make the luminescent signal brighter, the pMV306Lux+Hsp60+G13 plasmid will be
modified further by cloning an additional FMN reductase into the operon. This new FMN
reductase is expected to add more reducing power to the operon, creating a brighter luminescent
signal that is easier to detect.
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3. METHODS
3.1 FastCloning
pMV306Lux+hsp60+WhiB7, pMV306Lux+WhiB7+G13, and pVVRG+WhiB7 were
created through modification of the pMV306Lux+Hsp60+G13 plasmid. This plasmid, derived
from Photorhabdus luminescens, contains the luxAB genes under control of constitutive Phsp60
and the luxCDE genes under control of constitutive PG13 [10]. The promoters in this plasmid
were replaced by PwhiB7 using a method called FastCloning [18]. FastCloning is a ligation-free
cloning technique that can be used to insert a segment of DNA, referred to as an insert, into a
larger vector. Primers with overhangs corresponding to the reverse complement of the desired
insertion site in the vector were designed and used to amplify the insert piece through
polymerase chain reaction (PCR). To amplify the vector piece, a pair of primers were created
flanking the site of insertion. The following components were used in the FastCloning PCR
reaction: 5 L 1x GC Buffer, 0.2 mM dNTPs, 0.25 L Phusion, 16.25 L deionized water, 1 L
of 10 mM forward primer, 1 L of 10 mM reverse primer, and 20 ng/L template DNA. The
following PCR conditions were used to amplify both the insert and the vector pieces:
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Table 1: PCR Reaction Conditions

PCR Stage

Time (s)

Temperature (C)

Repeats

Initial Melting

30

98

1x

Melting

10

98

20x

Annealing

30

20x

Extension

15/ kilobase of DNA
replicated
180

Varies according to
annealing temperature
of primers
72
72

1x

Final Extension

20x

After PCR amplification, the sizes of the vector and insert pieces were verified by gel
electrophoresis. Once the desired pieces were obtained, they were combined in varying ratios:
4:1 vector to insert, 1:4 vector to insert, and 1:1 vector to insert. Each mixture was then
incubated with an enzyme called Dpn1 for at least one hour. Dpn1 acted to digest any remaining
unamplified plasmid DNA by targeting methylated DNA. The length of the Dpn1 incubation
may be extended overnight in order to ensure that all unamplified plasmid DNA was removed.
Next, the recombinant plasmids were transformed into E. coli cells. 2 L of each reaction mix
was introduced to NEB 10-Beta Competent E. coli and heat shocked at 42C for 30 seconds. The
cells were allowed to incubate on ice for 5 minutes before 250 L of SOC outgrowth media was
added. The cells were then shaken at 250 rpm and 37C for one hour before plating. The
plasmids used in this study contained kanamycin resistance genes to allow for the selection of
colonies containing the recombinant plasmid. Therefore, LB agar plates containing 50 g/L
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kanamycin (K50) were used to select for positive colonies containing the plasmid of interest.
After growth of the E. coli at 37C for 24 hours, colony PCR was used to further identify
positive clones containing the plasmid with the correct insertion. A small portion of each colony
was removed from the plate with a sterilized toothpick, placed in 20 L deionized water, and
boiled for 5 minutes. The lysate that resulted was used as template DNA for PCR reactions using
primers flanking the region of insertion. Gel electrophoresis was performed to identify the size of
the insertion, with one specific size correlating to proper gene insertion. The bacteria containing
the verified recombinant plasmids were grown up in culture and the plasmid DNA was purified
using a Qiagen Miniprep kit. This purified plasmid DNA was then sent for sequencing by
Eurofins.
3.2 Blunt Cloning
The pMV306Lux+WhiB7+LuxG13 plasmid was created through modification of the
pMV306Lux+Hsp60+G13 using a different cloning technique called Blunt Cloning. Primers
were designed to match each end of the piece of DNA that was inserted into the vector. These
primers were then phosphorylated using the following reaction mixture:
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Table 2: Primer Phosphorylation Components

Component

Volume (L)

Deionized Water

37

10X Kinase Buffer

5

MgSO4 (50 mM)

1

Primer (10 M)

5

ATP (100 mM)

1

T4 Polynucleotide Kinase

1

These components were then incubated for 60 minutes at 37C, then the T4 polynucleotide
kinase was inactivated by incubation for 5 minutes at 65C. The insert and vector pieces were
then amplified with the same PCR components and conditions as used in FastCloning, except
phosphorylated primers were used. The vector and insert fragments were visualized through gel
electrophoresis to verify that they were the correct size. The vector and insert samples were then
mixed in equal proportions and digested with Dpn1 for at least one hour at 37C. The vector and
insert were ligated using the following reaction mix:
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Table 3: Blunt Cloning Ligation Components

Component

Volume (L)

Deionized Water

8.75

Vector/Insert Mix

3

ATP (10 mM)

0.75

10X Fast-Link Buffer

1.5

Fast-Link DNA Ligase

1

The reaction mixture was incubated for 30 minutes at room temperature, then heat inactivated at
70C for 15 minutes. The recombinant plasmid was then transformed into E. coli as described
previously and screened appropriately to verify proper insertion.
3.3 Luminescence Assay
The luminescence of the bacteria containing the newly created luciferase plasmids was
tested using the luminescence assay and compared to the luminescence levels of bacteria
containing the unmodified luciferase plasmid. The luciferase reporters were first transformed by
electroporation into M. smegmatis (Msm) competent cells. The Msm competent cells were
prepared by growing Msm in 15 mL of 7H9 media until an optical density (OD) of 0.6. The cells
were then pelleted and the supernatant was removed. The cells were washed with 7.5 mL of cold
glycerol, pelleted, and washed again with 7.5 mL of cold glycerol. The cells were then pelleted
and washed with 1.5 mL of 7H9. The cells were pelleted once more and resuspended in 0.6 mL
of 7H9. 100 mL aliquots of these cells were made and stored at -80C.
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To transform the luciferase reporter plasmids into these electrocompetent Msm, 200-500
ng of DNA was added to 100 L of Msm competent cells. These cells were electroporated using
a BioRad Gene Pulse X at 2500 V, a capacitance of 25 F, and a resistance of 1000. The
electroporated cells were added to 250 L of LB Tween 80 media, and shaken for 4 hours at
37C. Positive clones were selected for by plating on LB agar containing K50. The Msm
containing the luciferase reporter were able to grow on these plates, and these colonies were
picked and grown up in 5 mL of LB Tween containing 5 L of K50. These cultures were grown
until an OD of 0.6 was reached. The Msm culture was then added to a white 96-well plate along
with two drugs known to induce the macrolide-sensitive PwhiB7: azithromycin (AZT) and
clarithromycin (CLR) [14]. 90 L of culture was added to each well along with 10 L of each
drug at the appropriate concentration (determined in the MIC experiment in section 3.5). The
plate was incubated at 37C and luminescence and optical density readings of each well was
taken by the Synergy H4 plate reader. These measurements were recorded at 0, 2, 4, 24, 48, and
72 hours post-induction.
3.4 Fluorescence Assay
A fluorescent transcriptional reporter called mCherry was used to compare luminescent
and fluorescent reporters. Using FastCloning, the PwhiB7 was placed 17 base pairs upstream of the
mCherry gene in place of the smyc promoter in the pVVRG plasmid, creating the pVVRG+WhiB7
reporter [19]. This recombinant plasmid was then transformed into E. coli competent cells and
positive clones were identified by colony PCR and verified by sequencing. The reporter plasmid
was purified using a Quiagen Miniprep Kit. The purified reporter plasmid was then
electroporated into Msm as previously described. The Msm were grown up in culture to an OD
14

of 0.6 and placed in a black 96-well plate along with AZT and CLR. Fluorescence (excitation
580 nm and emission at 615 nm) and optical density measurements were taken on a Synergy H1
plate reader to parallel the luciferase assay at 0, 2, 4, 24, 48, and 72 hours post-induction.
3.5 Alamar Blue MIC Assay
The induction of PWhiB7 depends on the concentration of antibiotic to which the bacteria
are exposed. For optimal performance of the transcriptional reporter, the concentration of
antibiotic used in the luciferase assay must be enough to induce the activation of PWhiB7 without
killing the bacteria themselves. This concentration was found by creating a minimum inhibitory
concentration (MIC) curve using an Alamar Blue assay. The bacteria containing the luciferase
plasmid were grown up to an optical density of 0.6. They were then filter sterilized and diluted to
an optical density of 0.0005. 24 L of culture was placed in a black, clear bottom 384 well plate
along with 6 L of AZT and CLR in descending concentrations. The plate was incubated at 37C
for two days. After this time, 6 L of reduction indicator Alamar Blue (0.02 w/v resazurin) was
added to each well and allowed to incubate for 4 hours. Alamar Blue was used to monitor the
health and metabolic functioning of the cells. The dye changes from an oxidized blue state to a
reduced pink state in the presence of living cells. Living cells maintain reducing power and turn
the solution pink, increasing its fluorescence, while dead cells will not change the color of the
dye [20]. The fluorescence of the bacteria in the presence of multiple concentrations of antibiotic
was used to determine the MIC for each drug. At 4 hours, the fluorescence (excitation: 560nm,
emission: 590 nm) was read using a Synergy 4 plate reader. The level of fluorescence indicated
whether the bacteria were dead or alive. The data, expressed as percent growth, were fitted by a
modified Gompertz model [21], and the MIC curve for each drug was generated using GraphPad
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Prism (version 7.0). The MIC was defined as the lowest drug concentration at which 99% of the
bacteria were killed.
3.6 Quantitative Real-Time PCR
Quantitative real-time PCR (qRT-PCR) was used to directly measure whiB7 mRNA
transcript levels for comparison with luminescent and fluorescent reporter readouts. First, RNA
was isolated from broth culture containing either the luciferase or mCherry reporter and 0.01
g/mL AZT. At timepoints of 0, 4, 24, 48, and 72 hours after addition of AZT, 15 mL aliquots of
broth culture containing each reporter were collected and centrifuged at 3,500 xg for 20 minutes.
The supernatant was removed and discarded, and the pellet was then washed and resuspended in
1 mL of GTC buffer (4 M guanidine thiocynate, 0.5% Na N-lauryl sarcosine, 25 mM sodium
citrate, and 0.1 M -mercaptoethanol). Each sample was then spun down again and washed with
1 mL of PBS + 0.1% Tween 80. Finally, the pellet was resuspended in 200 L of 5mg/mL
lysozyme and incubated for 15 minutes at room temperature. 0.75 mL of prewarmed Trizol was
then added to each sample. The samples were then transferred to screw cap tubes containing 0.5
mL of 0.1 mm silica beads and beaten in the Mini-BeadBeater 16 by Biospec for 2 minutes at
maximum speed. Then, 200 L of chloroform was added to each tube, and tubes were spun for
15 minutes at 12,000 rpm. The upper aqueous phase was removed from each sample, collected,
and placed in an RNase-free tube. 500 L of 100% RNase free EtOH was added to each sample.
The Qiagen RNeasy kit was then used to isolate the RNA. To ensure that no DNA contamination
was present in the RNA, Invirogen’s TurboDNAfree kit was used twice to DNase the samples.
The RNA concentration was then measured with a Nanodrop.
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The RNA samples were then converted to cDNA using BioRad’s iScript cDNA Synthesis
Kit. All RNA samples were first diluted to 50 ng/L. Then, cDNA was synthesized and a no
reverse transcriptase control was made for each sample according to the following reaction
mixture:

Table 4: cDNA Reaction Components

+ Reverse Transcriptase
Volume (L)
5

- Reverse Transcriptase
Volume (L)
5

Component

1.25

0

iScript Reverse Transcriptase

1.00

1.00

RNA (50 ng/L)

12.75

14

RNase – Free Water

20

20

Total Volume

The following PCR conditions were used to amplify the cDNA:

Table 5: cDNA PCR Conditions

Temperature (C)

Time (min)

25

5

42

30

85

5

4

∞
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5x iScript Reaction Mix

To detect the amount of whiB7 RNA present in each sample, primers were created
flanking a segment of the sigA gene (normalization control gene) and the whiB7 gene in Msm
chromosomal DNA. Then, BioRad’s iTaq Universal SYBR Green Supermix Kit was used to
create the following reaction: 1 L of each cDNA was combined with 5 L of iTaq SYBR green,
3 L of RNase-free water, and 0.5 L of forward primer and 0.5 L of reverse primer. This
mixture was placed in a Microamp Fast Optical 96-well plate. qRT-PCR of the samples was then
run on the QuantStudio 7 Flex System using the following PCR cycle:
Table 6: qRT-PCR Conditions

Time (s)

Temperature (C)

Ramp (C/s)

Repeats

20

95

2.05

1x

10

95

2.05

40x

20

56

1.71

40x

3.7 Addition of FMN Reductase
Msm gene 2921, an FMN reductase, was cloned using upstream of the luciferase operon using
FastCloning in order to improve brightness of the luminescent signal emitted. Previous research
by Gregor et. al. has shown that the addition of an FMN reductase to a luciferase reporter in E.
coli improves reporter brightness by regenerating additional FMNH2 for oxidation in the
luciferase reaction [12]. Therefore, the addition of Msm2921, an FMN reductase, was
hypothesized to increase the brightness of the luminescent signal from the luciferase reporter in
Msm. First, Msm2921 was placed under the control of constitutive PG13 using FastCloning as
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described previously. Then, G13+Msm2921 was cloned into pMV306Lux+Hsp60+G13
upstream of LuxAB, creating a new reporter: pMV306Lux+Hsp60+G13+Msm2921. The
recombinant plasmid was then transformed into E. coli, Miniprepped, sequenced, and
transformed into Msm. Positive clones were selected for using growth on LB Tween K50 plates.
Positive clones were then grown to an optical density of 0.6 in 5 mL of LB Tween 80 containing
5 L K50. 100 L of Msm containing pMV306Lux+Hsp60+G13+Msm2921 were placed in a
white 96-well plate and luminescence of the samples was read by a Synergy H1 Plate Reader.
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4. RESULTS
4.1 Optimization of the Luciferase Transcriptional Reporter
pMV306Lux+Hsp60+G13 was edited so that PwhiB7 would replace one of the two
constitutive promoters located in the plasmid: PHsp60 or PG13. First, PG13 was replaced by the druginducible PwhiB7, creating a new reporter called pMV306Lux+Hsp60+WhiB7. The goal of this
reporter was to emit a luminescent signal that correlates to the induction of PwhiB7 due to the
stress caused by AZT or CLR. Figure 1 below shows a single replicate of the experiment
showing fold induction of the luminescent signal after addition of AZT (0.1 g/mL) or CLR
(0.01 g/mL).
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Fold Induction

20
15
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5
0
WhiB7+AZT

WhiB7+CLR

-5

G13+AZT

G13+CLR

Reporter
0 hrs

2 hrs

4 hrs

24 hrs

48 hrs

72 hrs

Figure 1: Induction of Luminescence of Unmodified Reporter Versus pMV306Lux+Hsp60+WhiB7. Fold
induction refers to luminescence normalized to optical density and compared to the signal from the same reporter
without induction by drugs. Error bars signify standard deviation in all figures, unless otherwise stated. A single
replicate of the luminescence assay was performed in triplicate wells. The unmodified reporter was exposed to 0.1
g/mL AZT (G13+AZT) and 0.01 g/mL CLR (G13+CLR). The inducible substrate reporter was exposed to the
same concentrations (WhiB7+AZT and WhiB7+CLR).
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The fold induction values were normalized to the optical density of the culture at each timepoint.
The cultures containing the unmodified pMV306Lux+Hsp60+G13 reporter (labeled G13+AZT
and G13+CLR) showed little induction of luminescent signal due to the lack of P whiB7. The
cultures containing the pMV306Lux+Hsp60+WhiB7 reporter (labeled WhiB7+AZT and
WhiB7+CLR) showed a large induction in response to AZT and a moderate induction in
response to CLR. This decreased level of induction was thought to be due to the use of a
concentration of CLR that was too large, killing the bacteria.
4.2 Optimization of Drug Concentration
Because of the unexpected inconsistencies in luminescent signaling seen in reporters
stimulated by AZT versus CLR, it was hypothesized that the concentration of CLR may be too
high, causing the bacteria to die. Therefore, a Minimum Inhibitory Concentration (MIC) curve
was created to determine the proper CLR concentration needed to induce P whiB7 without killing
the bacteria. An MIC curve for AZT was also created to verify that the proper concentration of
AZT was being used in the assay. The MIC experiment utilized the unmodified
pMV306Lux+Hsp60+G13 reporter (referred to as G13) and pMV306Lux+Hsp60+WhiB7
reporter (referred to as WhiB7). The resulting MIC curves are shown in Figures 2 and 3. Table 7
shows the calculated MIC values for AZT and CLR.

Table 7: AZT and CLR MIC Values

AZT

CLR

WhiB7 MIC (g/mL)

0.4452

0.05669

G13 MIC (g/mL)

0.4993

0.03085
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Figure 2: MIC Curve for AZT. Percent growth is shown for Msm containing either the unmodified reporter (G13)
or the inducible substrate reporter (WhiB7) when exposed to decreasing concentrations of AZT.

Figure 3: MIC Curve for CLR. Percent growth is shown for Msm containing either the unmodified reporter (G13)
or the inducible substrate reporter (WhiB7) when exposed to decreasing concentrations of CLR.
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Because the MIC value shows the lowest concentration of drug that prevents bacterial growth, it
was confirmed that the appropriate concentration of AZT was used in the luminescence assay of
less than 0.4 g/mL. The CLR MIC was reported as 0.04 g/mL, but 0.01g/mL CLR as used in
the experiment in Figure 1 was still not inducing the reporter. To further optimize the CLR
concentration needed for maximum induction, a luminescence assay was run on the unmodified
pMV306Lux+Hsp60+G13 reporter (referred as G13+CLR) and the inducible
pMV306Lux+Hsp60+WhiB7 reporter (referred to as WhiB7+CLR). This assay was used to
measure induction of these reporters in response to various concentrations of CLR. Results of
this experiment can be seen in Figure 4.
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Figure 4: Optimization of CLR Concentration for Luciferase Induction. Fold induction refers to luminescence
normalized to optical density and compared to the signal from the same reporter without induction by drugs. A
single replicate of the luminescence assay was performed in triplicate wells. The unmodified reporter was exposed
various concentrations of CLR (G13+AZT). The inducible substrate reporter was exposed to the same
concentrations (WhiB7+CLR).

23

This experiment showed that 0.005 g/mL CLR gave the largest induction of luminescent signal
in the pMV306Lux+Hsp60+WhiB7 reporter, so this concentration of CLR was used in future
experiments.
4.3 Comparison of Promoter Localization in the Luciferase Plasmid
PHsp60 in pMV306Lux+Hsp60+G13 was then replaced by PwhiB7 in order to compare
which promoter configuration gives the best signaling. A new reporter was created called
pMV306Lux+WhiB7+G13. The performance of this reporter was tested against the unmodified
reporter and pMV306Lux+Hsp60+WhiB7. AZT was used at 0.1 g/mL and CLR was used at
0.005 g/mL as determined in the MIC experiment in section 4.2. Figure 5 represents a single
replicate of the experiment showing induction of luminescent signal for each reporter normalized

Fold Induction

to the optical density of each sample.
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Figure 5: Induction of Luminescence of pMV306Lux+Hsp60+WhiB7 Versus pMV306Lux+WhiB7+G13. Fold
induction refers to luminescence normalized to optical density and compared to the signal from the same reporter
without induction by drugs. A single replicate of the luminescence assay was performed in triplicate wells. The
unmodified reporter was exposed to 0.1 g/mL AZT (G13+AZT) and 0.005 g/mL CLR (G13+AZT). The inducible
substrate reporter was exposed to the same concentrations (WhiB7+Hsp60+AZT/CLR). The inducible enzyme
reporter was exposed to the same concentrations (WhiB7+G13+AZT/CLR)
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The unmodified reporter (labeled G13+AZT and G13+CLR) showed little induction in
response to drugs due to the lack of PwhiB7. Samples containing pMV306Lux+Hsp60+WhiB7
(labeled WhiB7+Hsp60+AZT and WhiB7+Hsp60+CLR) showed small increasing induction
over time until the 72 hour timepoint when the signal increased dramatically. Samples containing
pMV306Lux+WhiB7+G13 (labeled WhiB7+G13+AZT and WhiB7+G13+CLR) showed
increasing induction that peaked at 24 hours. In the case of each reporter, the induction caused by
CLR was not as strong as the induction caused by AZT. However, the lower concentration of
CLR did improve induction in comparison to that seen with 0.01 g/mL CLR (Figure 1). The
pMV306Lux+WhiB7+G13 reporter showed a large increase in induction at 24 hours while the
pMV306Lux+Hsp60+WhiB7 reporter was delayed in indicating this increase. Therefore, the
pMV306Lux+WhiB7+G13 reporter was used in the remaining luminescence assays because of
its superior kinetics.
4.4 Comparison of Luciferase and mCherry Transcriptional Reporters
In order to compare the efficacy of luminescent and fluorescent transcriptional reporters,
the mCherry plasmid was modified so that PwhiB7 controlled the expression of fluorescent protein
mCherry in response to stimulation by AZT and CLR. The fluorescence assay utilized the
pVVRG+WhiB7 reporter stimulated by AZT (0.1 g/mL) and CLR (0.005 g/mL). Fluorescence
values were normalized to the optical density of each sample as shown in the single experiment
in Figure 6. The fluorescence stimulated by AZT and CLR increases slowly over time, reaching
a peak at 48 hours followed by a decrease in signal at 72 hours. Once again, AZT stimulated a
greater fluorescent signal than CLR.
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Figure 6: Fluorescence of pVVRG+WhiB7. Fold induction refers to fluorescence normalized to optical density and
compared to the signal from the same reporter without induction by drugs. A single replicate of the fluorescence
assay was performed in triplicate wells. The whiB7 reporter was exposed to 0.1 g/mL AZT (WhiB7+AZT) and
0.005 g/mL CLR (WhiB7+CLR).
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4.5 Comparison of Transcriptional Reporters and Real-Time Transcription
In order to determine which reporter most accurately reflected actual gene expression in
terms of magnitude and kinetics, qRT-PCR was used. A portion of each culture was first used to
measure luminescence and fluorescence in a single experiment as shown in Figure 7. The
kinetics of the luciferase and mCherry reporters look quite different. As can be seen in Figure 7,
the pMV306Lux+Hsp60+G13 reporter was not induced by AZT because it lacked P whiB7. The
pMV306Lux+WhiB7+G13 reporter was chosen for comparison with the unmodified reporter
because it showed improved induction over the pMV306Lux+Hsp60+WhiB7 reporter (Figure 5).
The induction of this reporter peaked at 24 hours and decreased thereafter at both 48 and 72
hours. The fluorescence of the pVVRG+WhiB7 reporter was compared with the luciferase
reporter. Figure 7 also shows that the fluorescent reporter’s fold induction increased throughout
the experiment, but only reached a maximum of less than 4 fold induction. This is about 3 times
smaller than the maximum induction seen in the pMV306Lux+Hsp60+WhiB7 reporter.
Additionally, the signal emitted by the mCherry reporter could not be detected at the four hour
timepoint, while the luciferase reporter already showed 4 fold induction at this time. In order to
examine the kinetics of these reporters with actual mRNA expression, the remaining culture was
used to extract RNA for qRT-PCR. The fold regulation for each culture stimulated by AZT (0.1
g/mL) is represented by the average values of two experiments shown in Figure 8.
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Figure 7: Luminescent vs. Fluorescent Reporter. Fold induction refers to luminescence normalized to optical
density and compared to the signal from the same reporter without induction by drugs. A single replicate of each
assay was performed in triplicate wells. The unmodified luciferase reporter was exposed to 0.1 g/mL AZT
(Lux+Hsp60+G13, AZT). The inducible enzyme luciferase reporter was exposed to the same concentrations
(Lux+WhiB7+G13, AZT). The signal unmodified fluorescent reporter (pVVRG, AZT) was also measured compared
to the signal from the inducible fluorescent reporter (pVVRG+WhiB7, AZT) when exposed to 0.1 g/mL AZT.
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Figure 8: qRT-PCR Fold Induction of Msm Containing mCherry vs. Luciferase Reporter. Fold induction
refers to measurements of whiB7 mRNA levels in comparison to mRNA levels of the housekeeping gene sigA. Two
replicates of the experiment were performed in triplicate wells and averaged. Levels of whiB7 mRNA were
measured from Msm containing the fluorescent reporter (mCherry) and the luminescent reporter (Luciferase).
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The pMV306Lux+WhiB7+G13 reporter stimulated by AZT shows maximum luminescence at 24
hours, and the fold induction seen in the qRT-PCR experiment also peaks at 24 hours for these
bacteria. After this point, fold induction values decrease in the qRT-PCR experiment, and
luminescence decreases as well. The pVVRG+WhiB7 reporter shows increasing fluorescence
throughout the fluorescence assay with the highest induction reported at 72 hours. However, the
fold induction values seen in the qRT-PCR for the bacteria containing the mCherry reporter
seem to increase until 24 and 48 hours and decrease drastically at 72 hours. The mCherry
reporter used did not indicate this decrease in mRNA expression, instead showing increased
fluorescence over the course of 72 hours.
4.6 Enhancing Luminescent Signaling
One drawback that has been noted with luciferase-based transcriptional reporters is their
relatively low brightness. It was hypothesized, based on the research of Gregor et al., that the
addition of an extra FMN reductase would add more reducing power to the LuxCDABE operon
by regenerating additional 𝐹𝑀𝑁𝐻2 for oxidation as part of the luciferase reaction [12]. This
addition was shown to increase the brightness of the luminescent signal produced by the
reaction. Therefore, Msm2921, an FMN reductase, was placed under the control of constitutive
PG13 and cloned into pMV306Lux+Hsp60+G13, creating the
pMV306Lux+Hsp60+G13+Msm2921 reporter. Msm containing this reporter were cultured and
their luminescence level was read and compared to the unmodified pMV306Lux+Hsp60+G13
reporter. Figure 10 shows the luminescence values normalized to the optical density of each
sample performed in a single experiment. pMV306Lux+Hsp60+G13+Msm2921(referred to as
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Lux+Msm2921 in Figure 10) showed a drastically decreased luminescent signal when compared
to unmodified pMV306Lux+Hsp60+G13.
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Figure 9: Luminescence of pMV306Lux+Hsp60+G13+Msm2921. Luminescence refers to luminescent signal
normalized to optical density. Luminescence was measured for the unmodified luciferase reporter (Lux) as well as
the luciferase reporter containing the additional FMN reductase (Lux+Msm2921)
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5. DISCUSSION
The goal of this study was to determine whether luminescent transcriptional reporters
offer more sensitive and dynamic readings than fluorescent reporters. This project also hoped to
optimize a luciferase-based transcriptional reporter for use in Mtb. The understanding of gene
expression is vital to the study of the pathogenesis of Mtb, so an effective transcriptional reporter
is an important tool for scientists to have available to them. Furthermore, transcriptional
reporters are versatile in that they can be used in drug discovery, in studying protein-protein
interactions, and in imaging bacteria in live animal models. This study hypothesized that a
luciferase-based transcriptional reporter emits signal that is closer to real-time gene expression
than fluorescent reporters and could be a better, more accurate tool to monitor gene expression in
Mycobacteria.
Two new luciferase-based transcriptional reporters were created as a part of this study:
pMV306Lux+Hsp60+WhiB7 and pMV306Lux+WhiB7+G13. The difference in these reporters
lies in which promoters control the creation of the enzyme and substrate used in the luciferase
reaction. The first reporter, pMV306Lux+Hsp60+WhiB7, contained constitutive PHsp60
controlling the creation of the luciferase enzyme, and drug-inducible PwhiB7 controlling the
formation of the reaction substrate, a long-chain aldehyde. The results of the luciferase assay
comparing these two reporters (Figure 5) showed that pMV306Lux+Hsp60+WhiB7 did not give
as high of a signal as pMV306Lux+WhiB7+G13. The pMV306Lux+WhiB7+G13 contained druginducible PwhiB7 in control of the formation of the luciferase enzyme, and the constitutive PG13
promoter in control of the formation of the substrate. This reporter showed a much faster
increase in signal, reaching a peak at 24 hours as opposed to the continuous increase in signal
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seen in pMV306Lux+Hsp60+WhiB7. Additionally, the fold induction of
pMV306Lux+WhiB7+G13 was about 7 times higher than that of pMV306Lux+Hsp60+WhiB7 at
24 hours. Figure 5 also shows a decrease in the luminescent signal of
pMV306Lux+Hsp60+WhiB7 at 48 hours that recovers at 72 hours. This decrease at the 48 hour
timepoint was not repeated in future luminescence experiments, so it was determined that this
result was most likely an outlier due to technical error. This data indicates that in order to give
the brightest luminescent signal, the production of the enzyme should be under the control of an
inducible promoter, while the substrate concentration should be saturating as it is controlled by a
constitutive promoter. This result is in agreement with the conclusions seen in a similar
experiment performed by Yagur-Kroll et. al. in E. coli [13]. In future studies, both the PHsp60 and
PG13 will be replaced with drug-inducible PwhiB7, and the luminescent output will be compared
with the other reporters.
The luciferase transcriptional reporters created in this study were also compared to a
fluorescent mCherry reporter. The production of the mCherry protein was placed under the
control of PwhiB7 in the pVVRG+WhiB7 reporter. The fold induction seen in this reporter in
response to drugs was compared its luminescent counterparts. Fluorescence levels in
pVVRG+WhiB7 increased more slowly than luminescence, with fluorescence first detectable at
24 hours induction and peaking at 48 hours (Figure 6). This is in contrast with the
pMV306Lux+WhiB7+G13 reporter, which emitted signal that was detectable at as early as 2
hours and peaked at 24 hours (Figure 5). Additionally, pVVRG+WhiB7 had a maximum fold
induction of 10 (Figure 6) compared to the maximum fold induction of
pMV306Lux+WhiB7+G13 at 35 (Figure 5). This 3.5 times increase in induction at a timepoint
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24 hours earlier shows that the luciferase reporter can be induced more quickly and to a greater
extent than the mCherry reporter under the control of the same promoter.
Both mCherry and luciferase reporter signals were compared to whiB7 mRNA expression
using qRT-PCR. This experiment was used to determine which reporter’s signaling most
accurately represented actual mRNA expression occurring in the bacteria. The signal emitted by
the luciferase reporter correlated well with RNA expression, with the highest level of both RNA
expression and luminescence reached at 24 hours and continuously decreasing at 48 and 72 hours
(Figures 7 and 8) . The mCherry reporter was not as accurate. Fluorescence values consistently
increased over 72 hours (Figure 7) for this reporter, but real-time fold induction values seemed to
peak at 24 and 48 hours, then decrease drastically at 72 hours (Figure 8). As expected, whiB7
mRNA expression followed the same basic trend in the bacteria containing mCherry and
luciferase reporters. However, the expression seen 72 hour timepoint differed between the two
reporters (Figure 8). The negative fold induction value for this timepoint in mCherry is most
likely an outlier due to technical error, but further testing would be required to determine if this
difference is consistent over multiple trials. Despite this uncertainty, it is clear that the luciferase
reporter more accurately models the kinetics of real-time gene expression than the mCherry
reporter. In the future, it is important that more replicates of qRT-PCR along with the
luminescence and fluorescence assays are performed to verify that this result is repeatable.
This study also attempted to enhance the brightness of the luminescent signal from
pMV306Lux+Hsp60+G13. The addition of Msm2921, an FMN reductase, was expected to
increase the luminescent signal by adding more reducing power to the luciferase reaction.
However, the addition of Msm2921 actually drastically decreased the luminescent signal as seen
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in Figure 9. Further testing needs to be performed to determine why this decrease in signal
occurs. It is possible that when Msm2921 was inserted into the plasmid, it may have disrupted
the expression of certain vital components in the LuxCDABE operon. In the future, Msm2921
should be cloned into different locations within pMV306Lux+Hsp60+G13 to see if it could
induce a higher luminescent signal when placed elsewhere.
This experiment yielded a transcriptional reporter for use in Mtb that is more sensitive
and more dynamic than previously used tools such as mCherry. This luciferase reporter more
accurately models real-time gene expression than mCherry. The luciferase reporter is also
advantageous because it allows researchers to visualize both upregulation and downregulation of
transcriptional activity. This advantage will be further demonstrated in future experiments
examining the kinetics of the luciferase versus mCherry reporter after antibiotic stimulation is
removed. Additionally, since the operon luxCDABE allows both enzyme and substrate
transcription to be controlled, this system is more easily manipulated and optimized. This
reporter also does not require the addition of exogenous substrate as other luciferase reporters do.
This is an advantage because these substrates are often toxic and may kill the cells that are being
studied. Keeping the cells alive throughout the visualization process allows the reporter to study
transcriptional activity in real time. In these ways, the luciferase reporter offers distinct
advantages over other methods.
The luciferase transcriptional reporter is also an adaptable tool that can be used for many
purposes in the study of Mtb. In future studies, the luciferase reporter can be used in
macrophages or in live animal models to monitor gene expression as infection progresses.
Additionally, luciferase can be used in methods such as bioluminescence resonance energy
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transfer (BRET). BRET can be used to monitor protein-protein interactions in real-time by
converting the blue signal given off in the luciferase reaction to a red signal if two protein
binding partners come into close proximity [9]. This method could be used as a screening tool
for inhibitors of protein-protein interactions which are important drug targets in Mtb. In the
future, the pMV306Lux+WhiB7+G13 reporter could be used to perform mechanism of action
screenings of potential new drugs. Using the reporter with the macrolide-inducible PwhiB7, new
drugs that could target the ribosome in Mtb could be identified.
In the study of Mtb, information about gene expression is vitally important. This study
yielded an optimized luciferase-based transcriptional reporter for use in Mtb. This study also
showed that this luminescent reporter gives signal that is more indicative of actual mRNA level
than its fluorescent counterpart. Using this tool, researchers can study how transcription is
induced by a variety of factors, including the presence of antibiotics, and the function of a gene
can be deduced. Additionally, this method may help to identify transcription factors needed for a
gene to be expressed, making the identification of new drug targets possible. In the future, this
tool could be used in vivo to monitor gene expression during infection of an animal or in a
macrophage. This deeper understanding of how genes are transcribed in Mtb could lead to the
identification of new drug targets and antibiotics, an important step in combating the rise of
drug-resistant TB.
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APPENDIX A: PLASMID MAPS
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Figure A1: pMV306Lux+Hsp60+G13 Transcriptional Reporter

Figure A2: pMV306Lux+Hsp60+WhiB7 Transcriptional Reporter
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Figure A3: pMV306Lux+WhiB7+G13 Transcriptional Reporter

Figure A4: pMV306Lux+Hsp60+G13+Msm2921
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Figure A5: pVVRG

Figure A6: pVVRG+WhiB7
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APPENDIX B: PRIMER TABLES
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Table B1: Cloning Primers

Primer Name
Lux_hsp60_FC_F

Primer Sequence
ggccaagacaattgcgg

Lux_hsp60_FC_R

gcgtcgttgtggtcacct

WhiB7_hsp60_FC_F

Aggtgaccacaacgacgcgtagaaaataggttgtgcgattca
g

WhiB7_hsp60_FC_R

ccgcaattgtcttggccgtgtttttccccctgcatct

WhiB7_G13_FC_FLong

aaatatacctaataggtaccgttcacggacaccacgct

Lux_whiB7_FC_F

Atgactaaaaaaatttcattcattattaacgg

Lux_whiB7_FC_R.2

cggtacctattaggtatatttcatgtgg
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Function
Forward
primer to
amplify
luciferase
vector without
hsp60
Reverse primer
to amplify
luciferase
vector without
hsp60
Forward
primer to
amplify the
whiB7
promoter and
insert in place
of hsp60
Reverse primer
to amplify the
whiB7
promoter and
insert in place
of hsp60
Extended
forward primer
to amplify the
whiB7
promoter and
insert in place
of G13
Forward
primer to
amplify
luciferase
vector and
remove G13
Reverse primer
to amplify
luciferase
vector and
remove G13

Primer Name
WhiB7_Lux_FC_F

WhiB7_Lux_FC_R

Msm2921_LuxCDE_FC_F.
2

Msm2921_LuxCDE_FC_R.
2

Lux_Msm2921_FC_F

Lux_Msm2921_FC_R

WhiB7_Blunt_FC_F

Primer Sequence
Function
aaatatacctaataggtaccggtagaaaataggttgtgcgattca Forward
g
primer to
amplify the
whiB7
promoter and
insert in place
of G13
atgaaatttttttagtcatgtgtttttccccctgcatct
Reverse primer
to amplify the
whiB7
promoter and
insert in place
of G13
gtaccaggaggatggcaaatatgacggtcatcgcgc
Forward
primer to
amplify
Msm2921 and
attach to G13
atcgataagcttgattgcaggatatcagcggattcccagg
Reverse primer
to amplify
Msm2921 and
attach to G13
ctcagcgcagcggga
Forward
primer to
amplify
luciferase
vector and
insert
G13+Msm292
1
gacgtgccaactaggtctcct
Reverse primer
to amplify
luciferase
vector insert
G13+Msm292
1
gtagaaaataggttgtgcgattcag
Blunt cloning
forward primer
to amplify
whiB7
promoter
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Primer Name
WhiB7_Blunt_FC_R

Primer Sequence
gtgtttttccccctgcatct

pVVmCh_FC-F

atggtcagcaagggcga

pVVmCh_FC-Rpro

ggtgccgacgatcctcta

WhiB7_pVV16_FC_F

tagaggatcgtcggcaccttcacggacaccacgct

WhiB7_pVV16_FC_R

tcgcccttgctgaccatgtgtttttccccctgcatct
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Function
Blunt cloning
reverse primer
to amplify
whiB7
promoter
Forward
primer to
amplify
pVVRGcor and
remove smyc
Reverse primer
to amplify
pVVRGcor and
remove smyc
Forward
primer to
amplify whiB7
promoter and
insert into
pVVRGcor
Reverse primer
to amplify
whiB7
promoter and
insert into
pVVRGcor

Table B2: Sequencing Primers

Primer Name
Lux_Msm2921_G13_Seq_F

Primer Sequence
ctctaagtggaaagaaattgcagg

Lux_Msm2921_G13_Seq_R gcgtccatcttgttgtcgtag

Lux_hsp60_seq_F

cgttatcccctgattctgtgg

Lux_hsp60_seq_R

ctgtcgacgatcattgcaatt

Lux_G13_Seq_F

gtgtggtgcgaaaagtgtattg

Lux_G13_Seq_R

gagagtcattcaatattggcagg

Lux_hsp60_seq_F.2

ggataaccgtattaccgcctt

Lux_hsp60_seq_R.2

ggtcatagagtcctcctgtcaa
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Function
Forward primer
to sequence
G13+Msm2921
in luciferase
vector
Reverse primer
to sequence
G13+Msm2921
in luciferase
vector
Forward primer
to sequence
around hsp60
in luciferase
vector
Reverse primer
to sequence
around hsp60
in luciferase
vector
Forward primer
to sequence
around G13 in
luciferase
vector
Reverse primer
to sequence
around G13 in
luciferase
vector
Forward primer
to sequence
around hsp60
in luciferase
vector
Reverse primer
to sequence
around hsp60
in luciferase
vector

Primer Name
Lux Hsp60 seq F.3

Primer Sequence
ttggagcgaacgacctacac

Lux Hsp60 seq R.3

aaactccgtgaaatgatgctcc

pVV16seqF2

gaactggcgcagttcctct

pVVmChseqR

ggttcaaggtgcacatggag

Function
Forward primer
to sequence
around hsp60
in luciferase
vector
Reverse primer
to sequence
around hsp60
in luciferase
vector
Forward primer
to sequence
around smyc in
pVVRGcor
Reverse primer
to sequence
around smyc in
pVVRGcor

Table B3: qRT-PCR Primers

Primer Name
Msm_SigA_qRT_F.3

Primer Sequence
gaggaagaagaagctgatgc

Msm_SigA_qRT_R.3

ctcttcctcgtcccacac

Msm_WhiB7_qRT_F.2

atgacatgcgagacgcg

Msm_WhiB7_qRT_R.2

cacggttcctgccgttcg
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Function
Forward
primer to
amplify sigA
Reverse
primer to
amplify sigA
Forward
primer to
amplify whiB7
Reverse
primer to
amplify whiB7
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